You are here

Agency Actions

Agency seeks comments on draft guidelines
Treatment controls cataplexy in patients with narcolepsy
Meeting aims to support relationships, cooperation, and joint investigations
Commission’s lawsuit cites false and unsubstantiated claims
Study evaluates it as potential first-line treatment in patients ineligible for cisplatin chemotherapy
Company seeks approval for pain relief at postsurgical site
Agency concerned about potential hepatotoxicity
Approval decision set for June 2017
Threat is “real, ever-present, and continually changing,” official says